Substances / GHB - GBL

GBL (gamma-butyrolactone) and BDO (1,4-butanediol) are GHB precursors, i.e. they are converted by the body into GHB (gamma-hydroxybutyric acid). GHB is closely related to the body's own gamma-aminobutyric acid (GABA) and activates certain GABA receptors. GABA is the most important inhibitory neurotransmitter in the brain and regulates, among other things, the sleep-wake rhythm, memory functions and growth hormones. Depending on the phase of action, dosage and individual metabolism, GHB/GBL/BDO can have a stimulating as well as a relaxing and calming effect. In medicine, GHB is used in the treatment of narcolepsy and in some countries also to treat withdrawal syndrome in alcohol addiction.

Effect

Extremely dose-dependent and varies greatly from person to person. The spectrum of effects ranges from euphoria, relaxation, disinhibition, increase in sexual desire, intensification of perception, urge to talk (babbling flash), slight dizziness and nausea, to drowsiness and deep sleep with unconsciousness (film rupture). GHB/GBL/BDO have a sexually stimulating effect and at the same time alter consciousness. Under the influence of these substances, you will assess situations differently. If you use GHB/GBL/BDO during sex, clarify boundaries, practices and protection with your sexual partners before use.

‍

Duration

Onset of effect

10-20 min. after ingestion

‍Effective duration

1-3 hrs.‍

Aftereffects

2-4 hrs.

Dosage

GHB and GBL are usually sold in liquid form, but GHB can also be found in powder form. The dosage of liquids depends on how diluted they are sold. Dosing GBL is even trickier than GHB, as not every body metabolizes the substance at the same rate. GBL is a strong acid that can corrode the mucous membranes and must be heavily diluted with a non-alcoholic drink before drinking.

If in doubt, the following applies: approach the dosage slowly to avoid unconsciousness and life-threatening consequences.

‍

The dosage information is based on 100 % pure content.

‍

Swallowed

Low dose

GHB: 1 - 2 ml (powder form: 0.5 - 1 gram)

GBL: 0.5 - 0.9 ml

BDO: 0.5 - 1.0 ml

Average dose

GHB: 2 - 3 ml (powder form: 1 - 2 grams)

GBL: 0.9 - 1.5 ml

BDO: 1.0 - 2.5 ml

High dose

GHB: 3 - 4 ml (powder form: 2 - 3 grams)

GBL: 1.5 - 2.0 ml

BDO: 2.5 - 4.0 ml

Narcotic dose

GHB: more than 4 ml (powder form: more than 3 grams)

GBL: more than 2.0 ml

BDO: more than 4.0 ml

‍

Invoice example:

Analyzed GHB: 75 %

1 ml liquid = 0.75 ml GHB

‍

So how much of my liquid do I need to take if I want a medium dose (2 ml of pure GHB)?

1 ml = 0.75 ml GHB

? = 2 ml GHB

average dose = 2 x 1 : 0.75 = 2.66 ml liquid

Risks

The higher the dose, the more likely headache, nausea, confusion, dizziness, uncontrollable muscle twitching, or unconsciousness will occur.

Already a deviation of one milliliter or the mixture with alcohol, sedatives or opiates can lead to overdose and life-threatening consequences up to death (respiratory depression!). Signs of an overdose are undisturbed or hardly disturbed sleep, unconsciousness, disappearance of reflexes and breathing difficulties. It is difficult to assess whether someone is only in deep sleep or is already in a life-threatening coma - if in doubt, always seek medical help.

Long-term risks:
Regular use can lead to sleep disorders, anxiety and tremors; there is a risk of addiction with psychological and physical symptoms. Chronic high-dose consumption (several doses a day) can lead to severe physical withdrawal symptoms such as epileptic seizures, which can be life-threatening. Regular use of high doses of GHB and, in particular, repeated unconsciousness as a result of GHB use (or mixed use with GHB) carry a high risk of developing persistent mental and intellectual impairment.

Safer Use

The substances are odorless. GHB tastes salty, GBL/BDO soapy. GBL has a strong corrosive effect, irritates the mucous membranes and stresses the liver.
Dilute GHB/GBL/BDO before taking it.

Avoid mixed consumption of any kind. Mixed consumption with alcohol, benzodiazepines and other tranquillizers as well as opiates (including codeine) can lead to life-threatening respiratory paralysis even in small quantities.
Even if GHB/GBL/BDO are not (yet) working, do not add more immediately. Topping up often leads to an unintentional overdose.
Refrain from consuming GHB/GBL/BDO when you are alone.
People with epilepsy, heart, liver, or kidney dysfunction take life-threatening risks when they consume it.
After regular use (daily), perform withdrawal only under medical supervision, as it can be life-threatening.

Mixed use

The consumption of alcohol before, during or after GHB/GBL/BDO use can lead to collapse even with small amounts of alcohol (risk of respiratory paralysis!). Mixed consumption with antiretroviral drugs (protease inhibitors, e.g. Kaletra, Reyataz, Crixivan, Norvir, Invirase) can increase the effect of GHB/GBL in a life-threatening manner even at low doses (risk of respiratory depression, coma, epileptic seizures!).

Substances

3-CMC (Clophedrone)

3-MMC (3-methylmethcathinone)

4-FA

4-MMC (mephedrone)

6-APB

DOM - DOI - DOB

MDA - MDEA - MBDB

Methylone

Synthetic cannabinoids

Sex

Increased risk behavior due to disinhibiting effect and increased sexual desire. Also abused to make others sexually submissive ("knockout drops").

Extender

No items found.

LSD analogues

LSD analogues are substances that are chemically very similar to LSD and can have comparable effects. Some of them have been known for a long time (e.g. ALD52, ETH-LAD, AL-LAD, PRO-LAD etc.) and have been studied pharmacologically as well as psychopharmacologically, at least in part. Others are newer "creations" (e.g. the derivatives 1P-LSD,1B-LSD, 1cP-LSD, 1V-LSDetc.), for which only few or no data are available. Certain LSD analogues can (still) be legally produced, traded and consumed in some countries, which is the main reason for their distribution.

Most LSD analogues are naturally different from LSD in their effect and/or potency (e.g. ETH-LAD, AL-LAD, LSZ etc.). In contrast, the so-called 1-acylated LSD compounds (e.g. 1P-LSD, 1V-LSD, 1B-LSD, ALD-52, etc.) are presumed, on the basis of pharmacological studies, to convert into LSD in the body (they function as so-called prodrugs) and thus have a comparable psychoactive effect to LSD.

In the case of prodrugs of LSD and LSD analogues, it has not been conclusively clarified whether, in addition to their psychoactive effect, they can produce other pharmacological effects. How potent these prodrugs are compared to the resulting substance (e.g., 1P-LSD to LSD), and to what extent a delay in onset of action occurs in each case, may be substance-dependent and cannot be generalized. Therefore, it is important to approach the dose/effect carefully to avoid overdoses.

‍

GHB - GBL - BDO

Effect

Duration

Dosage

Risks

Medicines

Emergency

Things to know

Current warnings

Advisory service

Downloads

Effect

Duration

Dosage

Risks

Effect

Dosage

Risks

Safer Use

Mixed use

Substances

Sex

Extender

LSD analogues

Medicines

Synthesis impurities

Emergency

Things to know

Current warnings

Advisory service

Downloads